XTX Topco’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$90.3K Buy
42,805
+29,699
+227% +$62.7K ﹤0.01% 1903
2025
Q1
$16K Sell
13,106
-4,556
-26% -$5.56K ﹤0.01% 2185
2024
Q4
$22.8K Buy
+17,662
New +$22.8K ﹤0.01% 2010
2021
Q3
Sell
-12,419
Closed -$40K 801
2021
Q2
$40K Buy
+12,419
New +$40K 0.01% 741